• by bcarlson@marketresearch.com
  • September 30 2014
  • ACA
  • IVD


PPACA One year Anniversary and the IVD Segment

PPACA One year Anniversary and the IVD Segment

Today marks the one year anniversary of when the Patient Protection and Affordable Care Act (PPACA) Health Insurance Exchange Marketplaces opened. Kalorama has analyzed the impact of the ACA on the in vitro diagnostics industry in the past. Let’s take a look at where things stand with respect to the Act and the IVD segment.

Improving economic conditions, the PPACA coverage expansions, and the aging of the population should drive faster projected growth in health spending in 2014 and beyond. Th...


Merck KgaA - Sigma Aldrich Creates Giant in Biotech Lab Supply

Merck KgaA - Sigma Aldrich Creates Giant in Biotech Lab Supply

This week, Merck KgaA announced it would buy Sigma-Aldrich for 17 billion dollars. The move creates a life science supplies giant that will contest Thermo Fisher in the life sciences research tools and reagents market. It no doubt reflects a response to the Thermo Flsher -Life Technology acquisition; In the cell culture market , that Kalorama has extensively covered over the years, Merck KgaA-Sigma creates a very close no. 2 player to Thermo-Fisher and possibly a new leader. On a secondary level...

  • by bcarlson@marketresearch.com
  • September 23 2014
  • proteomics


In Proteomics Market, Desire For New Therapies Meets Reality of Research Spending

In Proteomics Market, Desire For New Therapies Meets Reality of Research Spending

There’s a lot of interest in identification and validation of novel biomarkers that may represent potential drug targets or may lead to novel diagnostic tests As detailed in our complete study of the proteomics market, researchers are looking to proteomics for these discoveries. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles...


Advanced Disinfection Solutions in the Fight Against Ebola

Advanced Disinfection Solutions in the Fight Against Ebola

The deployment of U.S. military resources and a large aid package to Liberia, one of the hardest-hit countries in the West African Ebola outbreak, will include desperately needed disinfection equipment and supplies. Personnel in regional healthcare facilities have been decimated by the virus, and effective response made impossible without even basic supplies such as gloves and disinfectant. Beyond the current response to the Ebola outbreak that touches upon the base deficiencies of healthcare in...

  • by esalazar@marketresearch.com
  • September 16 2014
  • EMR


Kalorama, AMA, WSJ Bring Attention to EMR Falling Behind in a Device-Driven World

Kalorama, AMA, WSJ Bring Attention to EMR Falling Behind in a Device-Driven World

Physicians in the United States need only glance down at their iPhone or other handheld device to see what is missing in their current electronic medical record (EMR) office systems: an intuitive interface and advanced data-entry features that integrates seamlessly and assists in their everyday activities. Usability is a key product metric in the regulation-driven EMR market, and yet a predominant concern among users represented by the American Medical Association (AMA). In an interview with the...


Service Diversification Evident in U.S. Long Term Care Market

Service Diversification Evident in U.S. Long Term Care Market

Home care and assisted living - alternatives to nursing home care - are projected to add over six times the amount of annual revenue that nursing homes will add to the total U.S. long term care market by 2018. While demographic aging in the United States will buoy all service segments in the long term care market, growth will not be evenly spread amongst service providers. Including nursing homes, home care, hospice care and assisted living, the long term care market caters to the spectrum of ne...


Case Studies in Clinical Mass Spectrometry: An “Electronic Nose”

Case Studies in Clinical Mass Spectrometry: An “Electronic Nose”

Kalorama Information has profiled the unique and growing contributions of mass spectrometry technology to clinical in vitro diagnostics , and the pace of discovery in the field continues to impress. Researchers at the University of Leicester have developed an “electronic nose” capable of rapidly characterizing Clostridium difficile strains in infected patients. While the MALDI TOF form of mass spectrometry has been useful in identifying pathogens by cell surface proteins, the mass spec “electron...

  • by esalazar@marketresearch.com
  • September 5 2014
  • POL


How and Where IVD Will Find Growth in the Global POL Market

How and Where IVD Will Find Growth in the Global POL Market

Unlike laboratory medicine (or lab pathology), there is no settled role for professional point-of-care (POC) or “near-patient” testing (NPT) in modern healthcare systems. The use of decentralized IVD testing in primary and outpatient care, most often in physician office laboratories (POLs), is not uniform worldwide nor is it universally supported. Nonetheless, payers, regulators and administrators are forced to address POL testing as the capabilities of benchtop and portable IVD instruments and ...